Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

Cannabis stock news: Leading Cannabis Brand Launches First-Ever Dissolvable, CBD-Infused Drink Tablets

Dixie Brands' (CSE: DIXI.U), (OTC: DXBRF) Subsidiary, Aceso™ Hemp, Introduces Fizz Tabs, The Only CBD-Infused Dissolvable Tablets Available to Consumers


DENVER - May 22, 2019 ( Newswire) Today, Dixie Brands (CSE: DIXI.U), (OTC: DXBRF), (Frankfurt: 0QV), one of the cannabis industry's leading consumer packaged goods (CPG) companies, unveils a new product from its wholly owned subsidiary, Aceso™ Hemp. A growing line of indication-specific, hemp-derived supplements that promote optimal health, Aceso is proud to introduce Fizz Tabs, the first-ever line of dissolvable hemp-infused tablets to enter the cannabidiol (CBD) category. The line expansion creates an on-the-go option for consumers and promotes a powerful addition to wellness regimens.

"Aceso has been a pioneer in the hemp industry for years, allowing us to perfect sophisticated formulas based on herbalism that set the precedent for broad spectrum hemp," said Kurt Forstmann, Vice President of Corporate Business Development for Aceso. "Projections indicate that the CBD category is expected to be a 45 billion dollar ($45 billion) industry by 2024, and we're confident that our new Fizz Tabs are part of the next-generation of CBD products that are going to continue to set the pace for the category."

An evolution of Aceso's popular indication specific formulas, Calm, Soothe and Wellness, Fizz Tabs dissolve quickly in a glass of water, adding effervescence and flavor, and can be taken on an as needed basis with the benefits lasting for 4-6 hours. Designed in compact form for easy accessibility and convenience, the tablets are available in multiple flavors that each feature 10 mg of broad spectrum hemp per serving. The Fizz Tab line features:

  • Calm Fizz Tabs™ combine the calming properties of lavender, grapefruit and passionflower extracts with broad spectrum hemp oil to help people de-stress or reduce anxiety.
  • Soothe Fizz Tabs™ mix turmeric and bromelain with broad spectrum hemp oil to help ease daily aches and pains and reduce soreness.
  • Wellness Fizz Tabs™ are a blend of vitamins, broad spectrum hemp oil and capsaicin to promote energy, wellness and mood stability.

With a majority of brands in the CBD space providing rudimentary offerings, Aceso takes pride in the craft of creating effective products that use innovative formulas and natural ingredients. As one of the first entrants into the category, Aceso brings a deep understanding of the industry's complex regulatory structure and expertise in the production of safe, effective and compliant products that can be sold across the United States.

"As part of the cannabis industry's leading consumer packaged goods company, Aceso creates products that cater to consumers who are increasingly looking for natural alternatives in their wellness regimens with our three specific formulations: Calm, Soothe and Wellness, " said Hilal Tabsh, Vice President of Marketing and Distribution at Aceso. "Together, Aceso and Dixie have spent nearly a decade combined, investing in scientific research and technology that has unlocked the powers of hemp to deliver over-gratifying results for our consumers, and we're pleased to offer Fizz Tabs as a new and innovative extension of our ever-growing portfolio."

Aceso's Fizz Tabs are conveniently packaged individually in a box of 20, and are priced competitively at $22.00 per box. Calm and Soothe Fizz Tabs can be purchased now at, and Aceso Wellness Fizz Tabs will be available in June 2019.


Aceso Hemp is the next generation in hemp, pairing plant science with food science. Offering a growing line of indication-specific, hemp-derived supplements for promoting optimal health, Aceso Hemp was one of the first entrants in the category and brings a deep understanding of the industry's complex regulatory structure and expertise in the production of safe, effective and compliant products that can be sold across the United States. Aceso Hemp's scientists have studied, tested and perfected phyto-nutrient ratios that unlock the powers of hemp, resulting in sophisticated formulas that are easy for the body to absorb and activate. To find out more about Aceso Hemp's innovative products, visit


Dixie Brands Inc., through its licensed partners, has been formulating award-winning THC and CBD-infused products since 2009. Currently operating in five U.S. states, the Company is expecting to double its manufacturing and distribution capabilities in 2019 in the U.S. as well as expand internationally, including Canada and Latin America. Dixie leads the global industry in the development, packaging design, product innovation and quality control for the commercial production of cannabis infused products. While the Company started with a single flagship product, the Dixie Elixir (a THC-infused soda), it is now one of the industry's most recognized consumer brands, expanding to over 100 products across more than 15 different product categories representing the industry's finest edibles, tinctures, topicals and connoisseur grade extractions, as well as world-class CBD-infused wellness products and pet dietary supplements. Dixie's executive team has been instrumental in the formation of the marijuana industry for recreational and medicinal use, serving as founding members on several national regulatory and business-oriented industry organizations. To find out more about Dixie's innovative products, or about how Dixie is building the future of cannabis, visit

SOURCE Dixie Brands, Inc.

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories for Cannabis stocks and Psychedelic Stocks

Buy a cannabis guest post on